ScreenerHero

CLGNCollPlant Biotechnologies Ltd.

NAS · US · Healthcare · Biotechnology · collplant.com
0.3124USDMkt Cap: 5.91M $P/E: —

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap5.91M $
Enterprise Value2.89M $
Revenue (TTM)389.00K $
Gross Profit1.54M $
Net Income (TTM)-11.49M $
Revenue/Share0.0300 USD
Last Price0.3124 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees39
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.80
PEG—
EV/EBITDA-0.24
EV/Revenue7.44
P/S15.18
P/B0.92
EPS (TTM)-1.04
EPS (Forward)-0.39
52W Range
0.300062% of range0.3200
52W High0.3200 USD
52W Low0.3000 USD
Profitability
Gross Margin64.78%
Oper. Margin-4267.12%
EBITDA Margin0.00%
Profit Margin-484.56%
ROE-188.93%
ROA-106.53%
Growth
Revenue Growth-96.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.42M $
CapEx (TTM)28.00K $
FCF Margin-1716.90%
FCF Yield-113.07%
Net Debt-1.61M $
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity0.47
Current Ratio2.27
Quick Ratio1.84
Book Value/Sh0.3390 USD
Cash/Share0.2950 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 21, 2016
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.91M
Float6.99M
Insiders29.79%
Institutions9.93%
Short Interest
Short Ratio0.5d
Short % Float0.10%
Short % Out.0.08%
Shares Short15.03K
Short (prev mo.)33.72K
Technical
SMA 500.3321 (-5.9%)
SMA 2000.8653 (-63.9%)
Beta0.68
S&P 52W Chg19.18%
Avg Vol (30d)30.64K
Avg Vol (10d)86.55K
Technical Indicators
RSI (14)47.0
MACD-0.0048
MACD Signal-0.0067
MACD Hist.+0.0019
BB Upper0.3459 USD
BB Middle0.3146 USD
BB Lower0.2832 USD
BB Width19.95%
ATR (14)0.0367 USD
Vol Ratio (20d)0.47x